HiberCell Doses First Patient in Phase 1b Study Exploring Novel Combination of Odetiglucan and CD40…
<!-- Name:DistributionId Value:8844045 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value: -->…